Sitka Biopharma Overview

  • Founded
  • 2013

  • Status
  • Out of Business

  • Employees
  • 4

  • Latest Deal Type
  • Out of Business

Sitka Biopharma General Information


Developer of a nano-particle polymer platform technology designed to improve drug absorption for cancer treatments. The company's platform increases the absorption of drugs in difficult-to-penetrate tissues and addresses the absorption challenges of intravesical chemotherapy for bladder cancer, and later intraperitoneal delivery for ovarian cancer, enabling clinicians to transform chemotherapies to benefit patients by enhancing drug efficacy and improving tolerability.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Primary Office
  • 2500 - 1075 West Georgia Street
  • Vancouver, British Columbia V6E 3C9
  • Canada
+1 (604) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sitka Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Apr-2022 00.00 Completed Out of Business
4. Secondary Transaction - Private 25-Sep-2020 00.00 Completed Pre-Clinical Trials
3. Later Stage VC 11-Feb-2019 00.00 00.00 Completed Pre-Clinical Trials
2. Seed Round 07-Aug-2016 $2.4M $2.4M Completed Pre-Clinical Trials
1. Spin-Off 03-Dec-2013 Completed Pre-Clinical Trials
To view Sitka Biopharma’s complete valuation and funding history, request access »

Sitka Biopharma Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of a nano-particle polymer platform technology designed to improve drug absorption for cancer treatments. The
Drug Delivery
Vancouver, Canada
4 As of 2021
00000000 00 00.00

000 00

s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
0000 00000000
Debrecen, Hungary
00 As of 0000
0000000000 00.000


, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut
0000 00000000
Paris, France
00 As of 0000
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sitka Biopharma Competitors (52)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BBS Nanotech Theranostics Venture Capital-Backed Debrecen, Hungary 00 00.000 0000000000 00.000
00000 000000000000 Venture Capital-Backed Paris, France 00 000.00 00000000000 000.00
0000000 Venture Capital-Backed Cambridge, MA 000 00000000000 000
000000 Venture Capital-Backed Seattle, WA 00 00000 0000000000 00000
0000000 0000000000 Venture Capital-Backed Maastricht, Netherlands 00 000.00 0000000000 000.00
You’re viewing 5 of 52 competitors. Get the full list »

Sitka Biopharma Executive Team (5)

Name Title Board Seat Contact Info
Robert Geckeler Chief Development Officer
Kaley Wilson Ph.D Interim Chief Executive Officer & Board Member
You’re viewing 2 of 5 executive team members. Get the full list »

Sitka Biopharma Board Members (6)

Name Representing Role Since
Gordon McCauley CDRD Ventures Board Member 000 0000
Jack Geltosky Ph.D Self Board Member 000 0000
Kaley Wilson Ph.D Self Interim Chief Executive Officer & Board Member 000 0000
Karim Lalji CDRD Ventures Chairman 000 0000
Karimah Es Sabar Quark Venture Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Sitka Biopharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial